A NIF-TY DIAGNOSIS: A CASE OF IMMUNE CHECKPOINT INHIBITOR-INDUCED MYASTHENIA GRAVIS MANIFESTING AS RESPIRATORY FAILURE

被引：0
|
作者：
Dunn, Ariel Cole
McCall, Buckley
Wilson, Matthew
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
10.1016/j.chest.2024.06.1737
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2872A / 2873A
页数：2
相关论文
共 50 条
  • [31] Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report
    Zhong, Peng
    Zhang, Cuizhen
    Guan, Hongshan
    Yan, Jie
    He, Mengying
    Zhou, Xiaoyang
    CLINICAL CASE REPORTS, 2023, 11 (03):
  • [32] Immune checkpoint inhibitor-induced polyarthritis: a case series
    Smith-Uffen, Megan
    Tselios, Konstantinos
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12)
  • [33] IMMUNE CHECKPOINT INHIBITOR-INDUCED THYROIDITIS: CASE REPORT
    Aloyan, T.
    Antonov, E.
    Salimova, D.
    Chandra, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S105 - S105
  • [34] IMMUNE CHECKPOINT INHIBITOR-INDUCED POLYARTHRITIS: A CASE SERIES
    Smith-Uffen, Megan
    Tselios, Konstantinos
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1288 - A1288
  • [35] Overcoming challenges of immune checkpoint inhibitor-induced myocarditis diagnosis
    Cautela, Jennifer
    Deharo, Francois
    Thuny, Franck
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2023, 116 (10) : 429 - 432
  • [36] Rechallenge of immune checkpoint inhibitor after pembrolizumab-induced myasthenia gravis
    Tedbirt, Billal
    De Pontville, Michel
    Branger, Pierre
    Picard, Camille
    Baroudjian, Barouyr
    Lebbe, Celeste
    Carpentier, Antoine F.
    Delyon, Julie
    EUROPEAN JOURNAL OF CANCER, 2019, 113 : 72 - 74
  • [37] Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single-center case series
    Longinow, Joshua
    Zmaili, Mohammad
    Skoza, Warren
    Kondoleon, Nicholas
    Marquardt, Robert
    Calabrese, Cassandra
    Funchain, Pauline
    Moudgil, Rohit
    CANCER MEDICINE, 2023, 12 (03): : 2281 - 2289
  • [38] Characterization of Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System
    Niimura, Takahiro
    Zamami, Yoshito
    Miyata, Koji
    Mikami, Takahisa
    Asada, Mizuho
    Fukushima, Keijo
    Yoshino, Masaki
    Mitsuboshi, Satoru
    Okada, Naoto
    Hamano, Hirofumi
    Sakurada, Takumi
    Matsuoka-Ando, Rie
    Aizawa, Fuka
    Yagi, Kenta
    Goda, Mitsuhiro
    Chuma, Masayuki
    Koyama, Toshihiro
    Izawa-Ishizawa, Yuki
    Yanagawa, Hiroaki
    Fujino, Hiromichi
    Yamanishi, Yoshihiro
    Ishizawa, Keisuke
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (04): : 473 - 479
  • [39] IMMUNE CHECKPOINT INHIBITOR-INDUCED FANCONI SYNDROME: A CASE REPORT
    Farid, Saira
    Latif, Hira
    Nilubol, Chanigan
    Kim, Chul
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 568 - 568
  • [40] Recurrent Immune Checkpoint Inhibitor-Induced Colitis: A Case Report
    Lloyd, Adam
    Pathirana, Induruwa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S908 - S908
12345